Belumosudil (Rezurock)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 23:53, 22 July 2023 by Jwarner (talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

ROCK2 (Rho-associated coiled-coil kinase 2) inhibitor

Diseases for which it is used

Graft versus host disease

History of changes in FDA indication

2021-07-16: Approved for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy. (Based on ROCKstar)

Also known as

Code names: KD025, SLx-2119
Brand name: Rezurock

Retrieved from "https://hemonc.org/w/index.php?title=Belumosudil_(Rezurock)&oldid=75506"